Rare versus common diseases: a false dichotomy in precision medicine
Abstract Precision medicine initiatives are being launched worldwide, each with the capacity to sequence many thousands to millions of human genomes. At the strategic planning level, all are debating the extent to which these resources will be directed towards rare diseases (and cancers) versus comm...
Guardado en:
Autores principales: | Brian Hon Yin Chung, Jeffrey Fong Ting Chau, Gane Ka-Shu Wong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3ca45e3c8a6448cdb0b7af16aa613949 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rare and common regulatory variation in population-scale sequenced human genomes.
por: Stephen B Montgomery, et al.
Publicado: (2011) -
Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations.
por: Madeline H Kowalski, et al.
Publicado: (2019) -
Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer.
por: Edward J Saunders, et al.
Publicado: (2014) -
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
por: Christoph Röcken, et al.
Publicado: (2021) -
The Sequencing Quality Control 2 study: establishing community standards for sequencing in precision medicine
por: Tim R. Mercer, et al.
Publicado: (2021)